3rd Quarter - Report

THE WASHINGTON TAX & PUBLIC POLICY GROUP for ALPHARMA INC

Period 3rd Quarter 2008 Filed Oct 20, 2008 Signed by BARBARA ANGUS, PRINCIPAL

Official filing
Firm
THE WASHINGTON TAX & PUBLIC POLICY GROUP
Client
ALPHARMA INC
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension and expansion of alternative simplified research and development tax credit; HR 2138; S. 41; HR.3996; S.2209; HR. 6049; S. 3098; S.3125; S.3335; HR.7060; HR.7202; HR.1424; Subpart F issues, including treatment of manufacturing under IRC section 954 and related regulations; IRS REG-124590-07; IRC section 7701(economic substance doctrine); S.2242; HR.3970; HR.4351.

LobbyistCovered position, as disclosed
BARBARA ANGUS —
GREGORY NICKERSON —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE

Bills named: S. 3098 (110th), H.R. 4351 (110th), H.R. 7060 (110th), S. 41 (110th), S. 3125 (110th), S. 2209 (110th), H.R. 2138 (110th), H.R. 3970 (110th), H.R. 7202 (110th), S. 2242 (110th), S. 3335 (110th), H.R. 1424 (110th), H.R. 6049 (110th), H.R. 3996 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.